Related Experiment Video
Updated: Feb 27, 2026

A Phenotyping Regimen for Genetically Modified Mice Used to Study Genes Implicated in Human Diseases of Aging
Published on: July 14, 2016
Human U3 protein 14a plays an anti-apoptotic role in cancer cells
Abstract:
Human U three protein 14a (hUTP14a) binds p53 and promotes p53 degradation. Here, we report that hUTP14a plays an anti-apoptotic role in tumor cells through a p53-independent pathway. Knockdown of hUTP14a activated the intrinsic pathway of apoptosis and sensitized tumor cells to chemotherapeutic drug-induced apoptosis. In addition, the protein level of hUTP14a decreased upon chemotherapeutic drug- or irradiation-induced apoptosis. Importantly, the decrease of hUTP14a during induced apoptosis was not blocked by pan-caspase inhibitor z-VAD-FMK, indicating that the down-regulation of hUTP14a is an upstream event in apoptosis. Furthermore, ectopically expressed hUTP14a protected tumor cells from chemotherapeutic drug-induced apoptosis. In summary, our data showed that hUTP14a protected tumor cells from chemotherapeutic drug-induced apoptosis and thus might possess a potential as a target for anti-tumor therapy.
Insights
Human U three protein 14a (hUTP14a) protects tumor cells from apoptosis via a p53-independent pathway. Its down-regulation precedes apoptosis, suggesting hUTP14a is a potential anti-tumor therapy target.
Area of Science:
- Molecular Biology
- Cell Biology
- Cancer Research
Background:
- Human U three protein 14a (hUTP14a) is known to bind and promote p53 degradation.
- The role of hUTP14a in tumor cell survival and apoptosis remains incompletely understood.
Purpose of the Study:
- To investigate the role of hUTP14a in tumor cell apoptosis, particularly in response to chemotherapy.
- To elucidate the mechanism by which hUTP14a influences apoptosis and its potential as a therapeutic target.
Main Methods:
- Knockdown of hUTP14a using RNA interference.
- Induction of apoptosis using chemotherapeutic drugs and irradiation.
- Western blot analysis to assess protein levels.
- Treatment with pan-caspase inhibitor z-VAD-FMK.
- Ectopic expression of hUTP14a.
Main Results:
- Knockdown of hUTP14a activated the intrinsic apoptosis pathway and sensitized tumor cells to chemotherapy.
- hUTP14a protein levels decreased upon chemotherapy or irradiation-induced apoptosis, independent of caspase activity.
- Ectopic expression of hUTP14a conferred protection against chemotherapeutic drug-induced apoptosis.
- hUTP14a functions independently of p53 in mediating anti-apoptotic effects.
Conclusions:
- hUTP14a plays a significant anti-apoptotic role in tumor cells through a p53-independent mechanism.
- The down-regulation of hUTP14a is an early event in apoptosis.
- hUTP14a represents a promising therapeutic target for enhancing anti-tumor therapies.
Related Concept Videos
Abnormal Proliferation
The Intrinsic Apoptotic Pathway
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Caspases

